Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 to the Record History. Removed Revision: v3.3.3 from the Record History.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history gained a new entry 'Revision: v3.3.3' and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check32 days agoChange DetectedVersion 14 adds Contacts/Locations and Study Status sections to the Record History page on 2025-12-12. A deletion occurred on 2024-11-05.SummaryDifference0.5%

- Check46 days agoChange DetectedA new revision entry v3.3.2 was added and the previous revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry, v3.3.1, was added to the Revision History, and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding status notice at the top of the page was removed. Other page content appears unchanged.SummaryDifference0.7%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.